‘Miracle’ Cystic Fibrosis Drug Kept Out of Reach in Developing Countries

The New York Times - Business:

Vertex Pharmaceuticals is not making its drug, Trikafta, available in poorer countries, where thousands of diagnosed patients stand to benefit.

Author: Stephanie Nolen and Rebecca Robbins

This post first appeared in The New York Times - Business. Read the original article.